Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liothyronine (L-T3) with BIT or as Monotherapy for Medulloblastoma
NCT07346157Phase 2Recruiting
- Start
- Aug 2026
- Primary completion
- Mar 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liothyronine in medulloblastoma. Started Aug 2026; status: recruiting.
02
Drugs
liothyronine
03
Conditions
medulloblastoma
Beyond the preview
Go deeper on NCT07346157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07346157.